Global and Region Human Rabies Immunoglobulin (IM) Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

    The report details the trend, potential and market size of Human Rabies Immunoglobulin (IM) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Human Rabies Immunoglobulin (IM)market, defines the market attractiveness level of Human Rabies Immunoglobulin (IM) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Human Rabies Immunoglobulin (IM) industry, describes the types of Human Rabies Immunoglobulin (IM) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Rabies Immunoglobulin (IM) market and the development prospects and opportunities of Human Rabies Immunoglobulin (IM) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Rabies Immunoglobulin (IM) market in Chapter 13.

    By Player:

    • Sichuan Yuanda Shuyang

    • Shuanglin Bio

    • Sanofi

    • CSL Behring

    • Bharat Serum

    • Shanghai RAAS

    • CNBG

    • Weiguang Bio

    • CBPO

    • Kamada

    • Grifols

    • VINS

    By Type:

    • ERIG

    • HRIG

    By End-User:

    • Category II Exposure

    • Category III Exposure

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Human Rabies Immunoglobulin (IM) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Human Rabies Immunoglobulin (IM) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Human Rabies Immunoglobulin (IM) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Human Rabies Immunoglobulin (IM) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Human Rabies Immunoglobulin (IM) Market Analysis and Outlook to 2022

    • 7.1 Global Human Rabies Immunoglobulin (IM) Consumption (2017-2022)

    • 7.2 United States Human Rabies Immunoglobulin (IM) Consumption (2017-2022)

    • 7.3 Europe Human Rabies Immunoglobulin (IM) Consumption (2017-2022)

    • 7.4 China Human Rabies Immunoglobulin (IM) Consumption (2017-2022)

    • 7.5 Japan Human Rabies Immunoglobulin (IM) Consumption (2017-2022)

    • 7.6 India Human Rabies Immunoglobulin (IM) Consumption (2017-2022)

    • 7.7 South Korea Human Rabies Immunoglobulin (IM) Consumption (2017-2022)

    8 Region and Country-wise Human Rabies Immunoglobulin (IM) Market Analysis and Outlook to 2028

    • 8.1 Global Human Rabies Immunoglobulin (IM) Consumption Forecast (2022-2028)

    • 8.2 United States Human Rabies Immunoglobulin (IM) Consumption Forecast (2022-2028)

    • 8.3 Europe Human Rabies Immunoglobulin (IM) Consumption Forecast (2022-2028)

    • 8.4 China Human Rabies Immunoglobulin (IM) Consumption Forecast (2022-2028)

    • 8.5 Japan Human Rabies Immunoglobulin (IM) Consumption Forecast (2022-2028)

    • 8.6 India Human Rabies Immunoglobulin (IM) Consumption Forecast (2022-2028)

    • 8.7 South Korea Human Rabies Immunoglobulin (IM) Consumption Forecast (2022-2028)

    9 Global Human Rabies Immunoglobulin (IM) Market Outlook by Types and Applications to 2022

    • 9.1 Global Human Rabies Immunoglobulin (IM) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global ERIG Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global HRIG Consumption and Growth Rate (2017-2022)

    • 9.2 Global Human Rabies Immunoglobulin (IM) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Category II Exposure Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Category III Exposure Consumption and Growth Rate (2017-2022)

    10 Global Human Rabies Immunoglobulin (IM) Market Outlook by Types and Applications to 2028

    • 10.1 Global Human Rabies Immunoglobulin (IM) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global ERIG Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global HRIG Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Human Rabies Immunoglobulin (IM) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Category II Exposure Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Category III Exposure Consumption Forecast and Growth Rate (2022-2028)

    11 Global Human Rabies Immunoglobulin (IM) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Human Rabies Immunoglobulin (IM) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Human Rabies Immunoglobulin (IM) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Human Rabies Immunoglobulin (IM) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Human Rabies Immunoglobulin (IM) Market Competitive Analysis

    • 14.1 Sichuan Yuanda Shuyang

      • 14.1.1 Sichuan Yuanda Shuyang Company Details

      • 14.1.2 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product and Service

    • 14.2 Shuanglin Bio

      • 14.2.1 Shuanglin Bio Company Details

      • 14.2.2 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product and Service

    • 14.3 Sanofi

      • 14.3.1 Sanofi Company Details

      • 14.3.2 Sanofi Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Human Rabies Immunoglobulin (IM) Product and Service

    • 14.4 CSL Behring

      • 14.4.1 CSL Behring Company Details

      • 14.4.2 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 CSL Behring Human Rabies Immunoglobulin (IM) Product and Service

    • 14.5 Bharat Serum

      • 14.5.1 Bharat Serum Company Details

      • 14.5.2 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bharat Serum Human Rabies Immunoglobulin (IM) Product and Service

    • 14.6 Shanghai RAAS

      • 14.6.1 Shanghai RAAS Company Details

      • 14.6.2 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product and Service

    • 14.7 CNBG

      • 14.7.1 CNBG Company Details

      • 14.7.2 CNBG Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 CNBG Human Rabies Immunoglobulin (IM) Product and Service

    • 14.8 Weiguang Bio

      • 14.8.1 Weiguang Bio Company Details

      • 14.8.2 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Product and Service

    • 14.9 CBPO

      • 14.9.1 CBPO Company Details

      • 14.9.2 CBPO Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 CBPO Human Rabies Immunoglobulin (IM) Product and Service

    • 14.10 Kamada

      • 14.10.1 Kamada Company Details

      • 14.10.2 Kamada Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Kamada Human Rabies Immunoglobulin (IM) Product and Service

    • 14.11 Grifols

      • 14.11.1 Grifols Company Details

      • 14.11.2 Grifols Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Grifols Human Rabies Immunoglobulin (IM) Product and Service

    • 14.12 VINS

      • 14.12.1 VINS Company Details

      • 14.12.2 VINS Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 VINS Human Rabies Immunoglobulin (IM) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Human Rabies Immunoglobulin (IM)

    • Figure Human Rabies Immunoglobulin (IM) Picture

    • Table Global Human Rabies Immunoglobulin (IM) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Rabies Immunoglobulin (IM) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Rabies Immunoglobulin (IM) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Human Rabies Immunoglobulin (IM) Consumption by Country (2017-2022)

    • Figure United States Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)

    • Table Europe Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)

    • Figure China Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)

    • Figure Japan Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)

    • Figure India Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)

    • Figure Global Human Rabies Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)

    • Figure United States Human Rabies Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Human Rabies Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Human Rabies Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Human Rabies Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Human Rabies Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Human Rabies Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ERIG Consumption and Growth Rate (2017-2022)

    • Figure Global HRIG Consumption and Growth Rate (2017-2022)

    • Figure Global Category II Exposure Consumption and Growth Rate (2017-2022)

    • Figure Global Category III Exposure Consumption and Growth Rate (2017-2022)

    • Figure Global ERIG Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HRIG Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Category II Exposure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Category III Exposure Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Human Rabies Immunoglobulin (IM) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Human Rabies Immunoglobulin (IM) Export by Region (Top 5 Countries) (2017-2028)

    • Table Sichuan Yuanda Shuyang (Foundation Year, Company Profile and etc.)

    • Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product and Service

    • Table Shuanglin Bio (Foundation Year, Company Profile and etc.)

    • Table Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shuanglin Bio Human Rabies Immunoglobulin (IM) Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Human Rabies Immunoglobulin (IM) Product and Service

    • Table CSL Behring (Foundation Year, Company Profile and etc.)

    • Table CSL Behring Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Behring Human Rabies Immunoglobulin (IM) Product and Service

    • Table Bharat Serum (Foundation Year, Company Profile and etc.)

    • Table Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bharat Serum Human Rabies Immunoglobulin (IM) Product and Service

    • Table Shanghai RAAS (Foundation Year, Company Profile and etc.)

    • Table Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai RAAS Human Rabies Immunoglobulin (IM) Product and Service

    • Table CNBG (Foundation Year, Company Profile and etc.)

    • Table CNBG Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CNBG Human Rabies Immunoglobulin (IM) Product and Service

    • Table Weiguang Bio (Foundation Year, Company Profile and etc.)

    • Table Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Weiguang Bio Human Rabies Immunoglobulin (IM) Product and Service

    • Table CBPO (Foundation Year, Company Profile and etc.)

    • Table CBPO Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CBPO Human Rabies Immunoglobulin (IM) Product and Service

    • Table Kamada (Foundation Year, Company Profile and etc.)

    • Table Kamada Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kamada Human Rabies Immunoglobulin (IM) Product and Service

    • Table Grifols (Foundation Year, Company Profile and etc.)

    • Table Grifols Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols Human Rabies Immunoglobulin (IM) Product and Service

    • Table VINS (Foundation Year, Company Profile and etc.)

    • Table VINS Human Rabies Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)

    • Table VINS Human Rabies Immunoglobulin (IM) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.